Significance of anti-HCV signal-to-cutoff ratio in predicting hepatitis C viremia

Korean Journal of Internal Medicine

Volumn 24, Issue 4, 2009, Pages 302-308

  Seo, Yeon Seok ^a   Jung, Eun Suk ^a   Kim, Jeong Han ^a   Jung, Young Kul ^a   Kim, Ji Hoon ^a   An, Hyonggin ^a   Yim, Hyung Joon ^a   Yeon, Jong Eun ^a   Byun, Kwan Soo ^a   Kim, Chang Duck ^a   Ryu, Ho Sang ^a   Um, Soon Ho ^a  

^a Korea University College of Medicine   (South Korea)

Author keywords

Antibody titer; Enzyme immunoassay; Hepatitis C virus; Viremia

Indexed keywords

ALANINE AMINOTRANSFERASE; VIRUS RNA;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; ENZYME IMMUNOASSAY; FEMALE; HEPATITIS C VIRUS; HUMAN; IMMUNOBLOTTING; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PARAMETER; PREDICTION; QUALITATIVE ANALYSIS; RECEIVER OPERATING CHARACTERISTIC; RNA ANALYSIS; SIGNAL TO CUTOFF RATIO; VIREMIA;

ADULT; AGED; FEMALE; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; RNA, VIRAL; VIREMIA;

EID: 72049128038     PISSN: 12263303     EISSN: 20056648     Source Type: Journal    
DOI: 10.3904/kjim.2009.24.4.302     Document Type: Article

References (22)

1. Strader DB, Wright T, Thomas DL, Seeff LB; American Association for the Study of Liver Diseases. Diagnosis, management, and treatment of hepatitis C. Hepatology 2004;39:1147-1171.
2. Memon MI, Memon MA. Hepatitis C: an epidemiological review. J Viral Hepat 2002;9:84-100.
3. Na HY PM, Park KS, Sohn YH, Joo YE, Kim SJ. Geographic characteristics of positivity of anti-HCV and hepatitis B surface antigen in Kwangju and Chonnam province: survey data of 6,790 health screenees. Korean J Gastroenterol 2001;38:177-184.
4. Park KS, Lee LY, Lee SG, et al. A study on markers of viral hepatitis in adults living in Daegu and Gyungbuk area. Korean J Gastroenterol 2003;41:473-479.
5. Colin C, Lanoir D, Touzet S, et al. Sensitivity and specificity of third-generation hepatitis C virus antibody detection assays: an analysis of the literature. J Viral Hepat 2001;8:87-95. (Pubitemid 32234861)
6. Alter MJ, Kuhnert WL, Finelli L; Centers for Disease Control and Prevention. Guidelines for laboratory testing and result reporting of antibody to hepatitis C virus. MMWR Recomm Rep 2003;52:1-13, 15.
7. Dal Molin G, Tiribelli C, Campello C. A rational use of laboratory tests in the diagnosis and management of hepatitis C virus infection. Ann Hepatol 2003;2:76-83.
8. Carithers RL Jr, Marquardt A, Gretch DR. Diagnostic testing for hepatitis C. Semin Liver Dis 2000;20:159-171.
9. Pawlotsky JM. Use and interpretation of virological tests for hepatitis C. Hepatology 2002;36(5 Suppl 1):S65-S73. (Pubitemid 35253465)
10. Pawlotsky JM, Lonjon I, Hezode C, et al. What strategy should be used for diagnosis of hepatitis C virus infection in clinical laboratories? Hepatology 1998;27:1700-1702.
11. Hanley JA, McNeil BJ. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 1983;148:839-843.
12. Teresa LW, Michael PM, Hepatitis C, et al. Zakim and Boyer's Hepatology. 5th ed. Philadelphia: Elsevier, 2006:665-686.
13. Chiquete E, Sanchez LV, Maldonado M, Quezada D, Panduro A. Prediction of the hepatitis C viremia using immunoassay data and clinical expertise. Ann Hepatol 2005;4:107-114.
14. Bossi V, Galli C. Quantitative signal of anti-HCV by an automated assay predicts viremia in a population at high prevalence of hepatitis C virus infection. J Clin Virol 2004;30:45-49. (Pubitemid 38457067)
15. Dufour DR, Talastas M, Fernandez MD, Harris B, Strader DB, Seeff LB. Low-positive anti-hepatitis C virus enzyme immunoassay results: an important predictor of low likelihood of hepatitis C infection. Clin Chem 2003;49:479-486. (Pubitemid 36250209)
16. Kim YS, Lee HS, Ahn YO. Factors associated with positive predictability of the anti-HCV ELISA method with confirmatory RT-PCR. J Korean Med Sci 1999;14:629-634.
17. Polywka S, Schroter M, Feucht HH, Zollner B, Laufs R. Relevance of reactivity in commercially available hepatitis C virus antibody assays. J Clin Microbiol 2001;39:1665-1668. (Pubitemid 32275491)
18. Sookoian S, Castano G. Evaluation of a third generation anti-HCV assay in predicting viremia in patients with positive HCV antibodies. Ann Hepatol 2002;1:179-182.
19. Ren FR, Lv QS, Zhuang H, et al. Significance of the signal-to-cutoff ratios of anti-hepatitis C virus enzyme immunoassays in screening of Chinese blood donors. Transfusion 2005;45:1816-1822. (Pubitemid 43923912)
20. Lanotte P, Dubois F, Le Pogam S, et al. The kinetics of antibodies against hepatitis C virus may predict viral clearance in exposed hemophiliacs. J Infect Dis 1998;178:556-559. (Pubitemid 28347945)
21. Kondili LA, Chionne P, Costantino A, et al. Infection rate and spontaneous seroreversion of anti-hepatitis C virus during the natural course of hepatitis C virus infection in the general population. Gut 2002;50:693-696. (Pubitemid 34407499)
22. Baumert TF, Wellnitz S, Aono S, et al. Antibodies against hepatitis C virus-like particles and viral clearance in acute and chronic hepatitis C. Hepatology 2000;32:610-617. (Pubitemid 30676922)